Today: 3 March 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

McDonald’s (MCD) Stock in December 2025: Price, Forecasts, Dividend Hike and Holiday Catalysts

McDonald’s (MCD) Stock in December 2025: Price, Forecasts, Dividend Hike and Holiday Catalysts

McDonald’s shares closed at $300.72 on December 2, down 0.9%, valuing the company at just over $210 billion. The board raised the quarterly dividend 5% to $1.86 per share, bringing yield to about 2.4–2.5%. Arrowstreet Capital increased its stake by 26.8%, while Solidarity Wealth cut holdings by 19.6%. The stock trades about 16% above some analysts’ estimated fair value.
3 December 2025
Warner Bros. Discovery (WBD) Stock on December 2, 2025: Netflix Cash Bid, Bidding War and Analyst Forecasts

Warner Bros. Discovery (WBD) Stock on December 2, 2025: Netflix Cash Bid, Bidding War and Analyst Forecasts

Warner Bros. Discovery shares closed at $24.53 on December 2, up 2.7% on heavy volume after reports that Netflix submitted a mostly cash bid in the second round of an auction for the company. The stock has more than doubled in 2025 and is near 52-week highs, driven by a bidding war involving Netflix, Paramount Skydance, and Comcast.
KLA Corporation (KLAC) Stock Soars on AI Chip Boom as Wall Street Lifts Price Targets – Latest News & Forecasts for December 2, 2025

KLA Corporation (KLAC) Stock Soars on AI Chip Boom as Wall Street Lifts Price Targets – Latest News & Forecasts for December 2, 2025

KLA Corporation shares closed at $1,189.86 on December 2, up 2.8%, nearing record highs as analysts raised price targets and cited strong AI chip demand. The stock has surged nearly 85% in 2025, with recent reports highlighting 20% EPS growth and 13% revenue growth in fiscal Q1. Trading volume reached 0.9 million shares, above historical averages.
Pure Storage (PSTG) Stock Soars, Then Stumbles: Q3 2026 Earnings, AI Growth Story and 2026 Forecast on December 2, 2025

Pure Storage (PSTG) Stock Soars, Then Stumbles: Q3 2026 Earnings, AI Growth Story and 2026 Forecast on December 2, 2025

Pure Storage reported Q3 FY26 revenue up 16% to $964.5 million and raised full-year guidance, but GAAP profitability and cash flow fell. Shares jumped 7% to close near $94.70, then dropped as much as 11% after hours. Market cap stands around $30 billion, with valuation metrics flagged as high by analysts. Norges Bank disclosed a $225 million stake; insiders have been net sellers recently.
Intuitive Surgical (ISRG) Stock on December 2, 2025: Da Vinci 5 Momentum, Insider Sale and 2026 Wall Street Forecasts

Intuitive Surgical (ISRG) Stock on December 2, 2025: Da Vinci 5 Momentum, Insider Sale and 2026 Wall Street Forecasts

Intuitive Surgical shares closed at $567.37 on December 1, down 1.07% but up 7.34% over the past month, with a market cap near $204 billion. Q3 2025 revenue rose 23% to $2.51 billion, beating forecasts, and non-GAAP EPS jumped 30% to $2.40. Institutional ownership remains above 80%. The company placed 427 da Vinci systems in Q3, including 240 of the new da Vinci 5 model.
3 December 2025
Forbes 30 Under 30 Class of 2026: Gen Z’s $3.8 Billion AI Revolution From Jalen Hurts to Ella Langley

Forbes 30 Under 30 Class of 2026: Gen Z’s $3.8 Billion AI Revolution From Jalen Hurts to Ella Langley

Forbes released its 15th annual 30 Under 30 list on December 2, 2025, naming 600 honorees across 20 industries. This year’s group commands $3.8 billion in funding and 200 million social media followers. Forbes tightened eligibility rules, requiring nominees to be under 30 by year-end and not repeat honorees. The 2026 list highlights a surge in Gen Z-led AI startups and cultural figures.
Prada Completes $1.4 Billion Versace Acquisition: What Comes Next for Italian Luxury

Prada Completes $1.4 Billion Versace Acquisition: What Comes Next for Italian Luxury

Prada Group completed its acquisition of Versace from Capri Holdings on December 2, 2025, in an all-cash deal valued between €1.25 and €1.3 billion. Versace will represent about 13% of Prada Group revenues. The deal followed regulatory approval after Capri’s failed merger with Tapestry earlier in the year. Prada funded the purchase largely through €1.5 billion in new debt.
Kalshi Soars to $11 Billion Valuation: How a $1 Billion Mega-Round and a Former Ballerina Are Redrawing the Prediction Market Map

Kalshi Soars to $11 Billion Valuation: How a $1 Billion Mega-Round and a Former Ballerina Are Redrawing the Prediction Market Map

Kalshi announced a $1 billion Series E funding round at an $11 billion valuation on December 2, led by Paradigm with backing from Sequoia and Andreessen Horowitz. The deal more than doubles Kalshi’s valuation in under two months. Cofounder Luana Lopes Lara, 29, becomes the youngest self-made woman billionaire, according to Forbes. Kalshi reports over $1 billion in weekly trading volume and millions of weekly users.
2 December 2025
CrowdStrike (CRWD) Tops Q3 2026 Earnings, Lifts Outlook on AI Demand as Valuation Debate Intensifies

CrowdStrike (CRWD) Tops Q3 2026 Earnings, Lifts Outlook on AI Demand as Valuation Debate Intensifies

CrowdStrike reported Q3 2026 revenue of $1.23 billion, up 22% year over year and slightly above forecasts. Annual recurring revenue reached $4.92 billion, with record net new ARR of $265 million. The company posted a GAAP net loss of $34 million but delivered non-GAAP net income of $245 million. Management raised its full-year outlook, citing strong demand for its AI-driven Falcon platform.
Polyrizon (PLRZ) Stock Soars Over 130% on Nasal Spray Breakthrough: Is This Micro-Cap Biotech the Next Big Winner or a Speculative Trap?

Polyrizon (PLRZ) Stock Soars Over 130% on Nasal Spray Breakthrough: Is This Micro-Cap Biotech the Next Big Winner or a Speculative Trap?

Polyrizon Ltd. shares surged 131.96% on December 2, 2025, closing at $7.33 after announcing a key manufacturing milestone for its PL-14 nasal spray. Intraday trading saw prices swing between $5.85 and $8.36 on volume over 148 million shares. The Israeli biotech, still pre-commercial with no approved products or revenue, now holds a market cap near $14–15 million.
Carvana (CVNA) Stock Today, December 2 2025: Price, Q3 2025 Earnings, Analyst Ratings and 2026 Forecast

Carvana (CVNA) Stock Today, December 2 2025: Price, Q3 2025 Earnings, Analyst Ratings and 2026 Forecast

Carvana shares closed at $382.18 on December 2, 2025, up 1.8% for the day, with trading volume near 2.9 million shares. The stock has surged about 80–90% in 2025 and delivered a 4,700% total return over three years, reaching a market cap of $84 billion. Q3 revenue rose 55% to $5.65 billion, with net income at $263 million. Volatility remains high after a week of sharp gains.
Constellation Energy (CEG) Stock on December 2, 2025: AI Powerhouse, Nuclear Restart and What It Means for Investors

Constellation Energy (CEG) Stock on December 2, 2025: AI Powerhouse, Nuclear Restart and What It Means for Investors

Constellation Energy closed at $363.67 on December 2, up 1.3% for the day and 62.9% year-to-date, but remains 11.7% below its October high. The company secured a $1 billion federal loan to restart Three Mile Island Unit 1 and signed major power deals with Microsoft and Meta. Wall Street rates the stock “Moderate Buy” with an average price target of $391–$402. Q3 earnings missed estimates, but full-year EPS guidance was narrowed.
2 December 2025
American Airlines Stock (AAL): Breakout Signals, Airbus Fix, and Wall Street Outlook as of December 2, 2025

American Airlines Stock (AAL): Breakout Signals, Airbus Fix, and Wall Street Outlook as of December 2, 2025

American Airlines stock closed at $14.27 on December 2, 2025, up 2% for the day and 27% since October 1. Market capitalization stands near $9.3 billion with a P/E ratio around 15–16. The company operated over 80,000 flights during the Thanksgiving period amid record U.S. passenger volumes. American is running Travel Tuesday fare sales and steep AAdvantage mile discounts.
2 December 2025
Palo Alto Networks (PANW) Stock Outlook on December 2, 2025: AI Security Leader, Rich Valuation

Palo Alto Networks (PANW) Stock Outlook on December 2, 2025: AI Security Leader, Rich Valuation

Palo Alto Networks shares traded near $190 on December 2, about 15% below their 52-week high. Fiscal Q1 2026 revenue rose 15–16% to $2.47 billion, beating estimates. The company announced a $3.35 billion deal to acquire Chronosphere and continues work on a $25 billion CyberArk purchase. Wall Street maintains a “Moderate Buy” rating, with price targets around $223–$225.
Accenture (ACN) Stock Jumps on OpenAI Deal: AI Pivot, Earnings Date and Wall Street Targets as of December 2, 2025

Accenture (ACN) Stock Jumps on OpenAI Deal: AI Pivot, Earnings Date and Wall Street Targets as of December 2, 2025

Accenture shares closed at $261 on December 2, 2025, up after announcing a partnership with OpenAI and confirming Q1 FY26 earnings for December 18. The stock remains about 34% below its 52-week high despite fiscal 2025 revenue rising 7% to $69.7 billion and free cash flow hitting $10.9 billion. Accenture pays an annual dividend of $6.52 per share, yielding 2.3–2.6%.
Super Micro Computer (SMCI) Stock in December 2025: Can the AI Server Star Rebound After a Brutal Sell‑Off?

Super Micro Computer (SMCI) Stock in December 2025: Can the AI Server Star Rebound After a Brutal Sell‑Off?

Super Micro Computer (SMCI) closed at $32.9 on December 2, down nearly 37% in November and over 50% from its 52-week high. The company missed fiscal Q1 2026 estimates with $5.0 billion in revenue and a 9.3% gross margin, its lowest in years. Analyst targets imply upside, but consensus remains “Hold.” Heavy insider selling and volatile trading persist amid competition and delayed AI server deliveries.
Amgen (AMGN) Stock Today: Earnings Momentum, Obesity Breakthroughs and Fresh December 2, 2025 Forecasts

Amgen (AMGN) Stock Today: Earnings Momentum, Obesity Breakthroughs and Fresh December 2, 2025 Forecasts

Amgen shares traded at $338.67 on December 2, 2025, up 0.35% and near 52-week highs after strong Q3 results and a raised 2025 outlook. Several institutional investors disclosed reduced AMGN holdings in Q2 filings. Technical analysts flagged a short-term bullish setup. The company’s obesity and cardiovascular drugs remain key pipeline drivers.
1 641 642 643 644 645 682
Go toTop